564 research outputs found

    Filling the Reading Void: Studying Reading Stamina in a Suburban High School through Action Research: A Companion Research Study

    Get PDF
    A common practice in elementary schools is to allow students silent reading time during school. Experts agree this is best practice due to the benefits to students, especially in vocabulary development and reading stamina. As students age, however, this practice tends to decline in favor of activities that are meant to teach vocabulary in isolation and test preparation skills. In addition to these activities, English language arts classes typically read and study novels together as a class for the purpose of studying literary devices and literary analysis. Because of these practices, secondary students tend to read less, which in turn decreases reading stamina. In order to best prepare students for college, careers, and citizenry, adolescent students need increased literacy and stamina. Penny Kittle (2013), noted writer and reading expert, wrote Book Love: Developing Depth, Stamina, and Passion in Adolescent Readers, in which she described implementing a method of individualized instruction focused on a balanced approach of silent reading scaffolded by teacher conferencing (50%), mentor text study to improve writing skills (25%), and whole-class study of canonical texts (25%). The researcher, an English language arts teacher at a suburban, low poverty high school in North Carolina, recognized stamina as a major issue with her students; therefore, she implemented Kittle’s (2013) protocol in an effort to address the problem. The researcher studied the implementation of the project, called the Book Love Initiative, using a mixed-methods action research design. A concurrent companion study at a rural, high poverty high school in South Carolina employed the same method to determine if the method has more far-reaching implications than if the research were only conducted at one site. Both companion studies found student attitudes towards reading improved, reading volume and stamina increased, and the overall classroom environment improved

    CVB4 In-Hospital Survival of Congestive Heart Failure Patients Treated with Dobutamine or Milrinone

    Get PDF

    Taking the Lead: Enhancing Student Learning and Professional Collaboration through Action Research

    Get PDF
    The purpose of this module is: To empower teachers in leadership development and leadership roles To foster mutual respect and communication between adults working together To encourage action research as a daily classroom practice View professional learning module.https://digitalcommons.gardner-webb.edu/improve/1016/thumbnail.jp

    Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

    Get PDF
    A 13-valent pneumococcal conjugate vaccine (PCV13), recently approved for use in adults, induced an overall superior functional antibody response compared with the 23-valent pneumococcal polysaccharide vaccine. PCV13 elicits immunological memory and provides a new approach to preventing pneumococcal disease in adults

    PIN19: ROUTINE CHILDHOOD VACCINATION AGAINST INFLUENZA:AN ANALYSIS OF CLINICAL AND ECONOMIC BENEFITS

    Get PDF

    Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US.</p> <p>Methods</p> <p>Using data from a large private multi-payer health insurance claims database (2000-2006), we identified all patients beginning chemotherapy for metastatic lung cancer. Healthcare resource use (inpatient, outpatient, medications) and costs were tallied over time from date of therapy initiation ("index date") to date of disenrollment from the health plan (in most instances, presumably due to death) or the end of the study period, whichever occurred first. Healthcare utilization and costs were characterized using Kaplan-Meier sample average methods.</p> <p>Results</p> <p>The study population consisted of 4068 patients; mean (SD) age was 65 (11) years. Over a median follow-up of 334 days, study subjects averaged 1.5 hospital admissions, 8.9 total inpatient days, and 69 physician office and hospital outpatient visits. Mean (95% CI) cumulative total healthcare costs were 125,849(125,849 (120,228, $131,231). Costs of outpatient medical services and inpatient care constituted 34% and 20% of total healthcare costs, respectively; corresponding estimates for outpatient chemotherapy and other medication were 22% and 24%.</p> <p>Conclusion</p> <p>Our study sheds additional light on the burden of metastatic lung cancer among patients receiving chemotherapy, in terms of total cost thru end of life as well as component costs by setting and type of service, and may be useful in informing medical resource allocation in this patient population.</p

    Management of Febrile Neutropenia - a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer

    Get PDF
    Background: Febrile neutropenia/leukopenia (FN/FL) is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy, but German data on economic consequences are limited. Patients and Methods: A prospective, multicentre, longitudinal, observational study was carried out to evaluate the occurrence of FN/FL and its impact on health resource utilization and costs in non-small cell lung cancer (NSCLC), lymphoproliferative disorder (LPD), and primary breast cancer (PBC) patients. Costs are presented from a hospital perspective. Results: A total of 325 consecutive patients (47% LPD, 37% NSCLC, 16% PBC; 46% women; 38% age >= 65 years) with 68 FN/FL episodes were evaluated. FN/FL occurred in 22% of the LPD patients, 8% of the NSCLC patients, and 27% of the PBC patients. 55 FN/FL episodes were associated with at least 1 hospital stay (LPD n = 34, NSCLC n = 10, PBC n = 11). Mean (median) cost per FN/FL episode requiring hospital care amounted to (sic) 3,950 ((sic) 2,355) and varied between (sic) 4,808 ((sic) 3,056) for LPD, (sic) 3,627 ((sic) 2,255) for NSCLC, and (sic) 1,827 ((sic) 1,969) for PBC patients. 12 FN/FL episodes (LPD n = 9, NSCLC n = 3) accounted for 60% of the total expenses. Main cost drivers were hospitalization and drugs (60 and 19% of the total costs). Conclusions: FN/FL treatment has economic relevance for hospitals. Costs vary between tumour types, being significantly higher for LPD compared to PBC patients. The impact of clinical characteristics on asymmetrically distributed costs needs further evaluation

    Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice

    Get PDF
    Background: Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. Methods: Data were obtained from a European (97%) and Australian (3%) observational study of patients with non-Hodgkin’s lymphoma (NHL) receiving CHOP (±rituximab) chemotherapy. For each patient, each cycle of chemotherapy within the course, and each occurrence of FN within cycles, was identified. Patients developing FN in a given cycle (“FN patients”), starting with the first, were matched to those who did not develop FN in that cycle (“comparison patients”), irrespective of subsequent FN events. FN-related healthcare costs (£2010) were tallied for the initial FN event as well as follow-on care and FN events in subsequent cycles. Results: Mean total cost was £5776 (95%CI £4928-£6713) higher for FN patients (n = 295) versus comparison patients, comprising £4051 (£3633-£4485) for the initial event and a difference of £1725 (£978-£2498) in subsequent cycles. Among FN patients requiring inpatient care (76% of all FN patients), mean total cost was higher by £7259 (£6327-£8205), comprising £5281 (£4810-£5774) for the initial hospitalization and a difference of £1978 (£1262-£2801) in subsequent cycles. Conclusions: Cost of chemotherapy-induced FN among NHL patients in European and Australian clinical practice is substantial; a sizable percentage is attributable to follow-on care and subsequent FN events
    corecore